ieumBio Co.,Ltd. will participate in the Boston International Biotechnology Summit 2026, taking place on October 23, 2026, in Cambridge, Massachusetts, USA.

The summit brings together biotechnology and pharmaceutical companies, researchers, investors, and industry leaders to discuss emerging innovations and foster international collaboration across the biotechnology sector.

Yumi Kim, PhD, Founder & CEO will represent ieumBio at the summit, connecting with potential customers and partners to explore opportunities for research collaboration and business development.

ieumBio is developing KilliSpan™, a proprietary longevity validation platform that leverages the naturally short-lived African turquoise killifish to rapidly generate lifespan and healthspan data on longevity interventions.

By enabling data generation within months rather than years, KilliSpan™ aims to address a critical bottleneck in longevity research and support faster, evidence-based decisions in preclinical R&D.

Through its participation in the summit, ieumBio plans to introduce the capabilities of KilliSpan™ to the global biotechnology community and explore opportunities for preclinical evaluation services, collaborative research, and strategic partnerships.

The event also provides an opportunity for ieumBio to strengthen its network within the U.S. biotechnology ecosystem and advance its international business development activities.

Event Information

● Event: Boston International Biotechnology Summit 2026

● Date: October 23, 2026

● Venue: CIC Cambridge, One Broadway, 5th Floor

● Address: Cambridge, Massachusetts 02142, USA

Official Website: https://bostonbiotechnologysummit.com/